One of the listed companies, Square Pharmaceuticals Limited discloses its financial reports for the second quarter, (October – December 23).
The company’s earnings per share (EPS) Tk 5.92 paisa in Q2 of the current financial year (October – December 23). EPS was Tk 5.78 paisa during the same period last year. NAV per share was Tk. 132.07 as of December 31, 2023.
Share this
